ResearcherThe Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)Active in the last 2 years

Shengliang Li

ORCID-verified (high confidence)As of 15 November 2026

Matched on ORCID iD 0000-0002-3890-8482; OpenAlex author ID A5028910367.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2026: 1 paper

Papers 1

NIR-II emissive nanomedicine of dimer-structured conjugated oligomer induces immunogenic cell death for photoimmunotherapy of pancreatic cancer. Last author DOI 10.1186/s12951-026-04873-6 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Cui Cen · 1 shared paper, 2026
- Paper NIR-II emissive nanomedicine of dimer-structured conjugated oligomer induces immunogenic cell death for photoimmunother… DOI 10.1186/s12951-026-04873-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.